By Shristi Achar A and Johann M Cherian (Reuters) – Even as higher costs of borrowing continue to choke dealmaking, fund managers and bankers believe smaller UK-listed firms remain attractive to[...]
Read moreHealth
Poor GenXers without dependents targeted by US debt ceiling work requirements
WASHINGTON (Reuters) – The debt ceiling deal that U.S. President Joe Biden and House Republican Kevin McCarthy agreed over the weekend adds new conditions to food aid that will impact one segmen[...]
Read moreA dog’s (longer) life: How to cover health costs for aging pets
By Chris Taylor NEW YORK (Reuters) – Jean Elliott has adopted a number of senior dogs over the years, the most recent being Auggie, a 12-year-old Pekingese relinquished at a shelter. When tests[...]
Read moreSoros Fund adds First Horizon, Horizon Therapeutics and bond ETF
By Carolina Mandl NEW YORK (Reuters) – Soros Fund Management, the family office of billionaire George Soros, added to its portfolio new shares in financial and healthcare companies and a bonds e[...]
Read moreWhat the world’s longest happiness study says about money
By Chris Taylor NEW YORK (Reuters) – For generations, society has grappled with the question of whether money brings happiness. Now a new book has some answers – with the data to back it u[...]
Read moreFor bear stock pickers, 2023 is full of rich pickings
By Nell Mackenzie LONDON (Reuters) – Well-known activist short-selling hedge funds expect to find more companies squeezed by tough economic conditions in 2023, potentially increasing instances w[...]
Read moreInvestors bet on greed and fear as China loosens COVID grip
By Samuel Shen and Summer Zhen SHANGHAI/HONG KONG (Reuters) -Investors caught off-guard by China’s dramatic COVID policy pivot are betting on both greed and fear as the economy starts to gradual[...]
Read moreThe Caregiver’s Lament: How to handle the costs of care
By Chris Taylor NEW YORK (Reuters) – You might know P.J. Byrne from the movies, most likely as one of the fast-living brokers alongside Leonardo DiCaprio in “The Wolf of Wall Street.[...]
Read moreAnalysis-U.S. midterms dampen Big Pharma hopes for drug price policy change
By Ahmed Aboulenein WASHINGTON (Reuters) – The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want to weaken a new law that allows the governm[...]
Read more